Methandrostenolone

Methandrostenolone binds androgen receptors with moderate affinity and aromatizes significantly to estrogen. It dramatically increases nitrogen retention and protein synthesis, producing rapid increases in muscle size and strength. The 17-alpha alkylation allows oral bioavailability at the cost of hepatotoxicity. Effects are felt within days of starting due to the short half-life.

Dianabol is a 17-alpha alkylated oral compound with no ester. The 17-AA modification allows it to survive first-pass liver metabolism. Half-life of 3-6 hours means blood levels fluctuate significantly with once-daily dosing — twice or three times daily dosing produces more stable levels. Some injectable forms exist but are rarely used.

Dianabol is the classic mass-building oral. It is used almost exclusively in bulking phases because the rapid water retention and size gains it produces are counterproductive to any goal involving a lean or conditioned appearance. Strength increases are dramatic and fast — often within the first week. It is used as a kickstart at the beginning of longer injectable cycles to produce results while the slower-acting compounds reach stable blood levels. Experienced users also use it mid-cycle when progress stalls. The size gained is real muscle combined with significant water retention, which creates the pumped, full look associated with classic bodybuilding.

Dianabol is almost always used as a kickstart alongside a testosterone base, most commonly Testosterone Enanthate or Cypionate. The oral runs for the first four to six weeks while the long-acting injectable reaches stable blood levels. It is sometimes used mid-cycle as a plateau breaker. It is rarely run alone because HPTA suppression without a testosterone base creates a poor hormonal environment. It is not combined with other hepatotoxic orals because the combined liver stress is not manageable.

• Originally developed for performance enhancement of US Olympic athletes
• Prescribed in some countries for osteoporosis and muscle wasting
• Used in hormone replacement in some Eastern European countries historically
• No longer approved for medical use in most Western countries

• Significant aromatization — gynecomastia and water retention without AI management
• Hepatotoxicity — dose and duration dependent, liver enzymes consistently elevated
• Severe HDL suppression — cardiovascular risk with extended use
• Blood pressure elevation from water retention and estrogen
• HPTA suppression — natural testosterone production shuts down
• Acne and androgenic effects on skin
• Male pattern baldness acceleration in susceptible individuals
• Virilization in women

The water retention Dianabol causes is frequently mistaken for muscle gain. When the cycle ends, a significant portion of the size gained disappears as water clears. Users who did not expect this interpret it as losing their gains and often return to the compound to restore the size, creating a cycle of dependence. Blood pressure elevation from aromatization and water retention is significant and often ignored. Gynecomastia risk is high because of the pronounced aromatization. Liver enzyme elevation is consistent and dose-dependent. The short half-life means twice or three times daily dosing is required for stable levels, which creates a compliance burden that leads to inconsistent blood levels when doses are missed.

Dianabol metabolites are detectable for approximately 5-6 weeks via urine testing. The metabolite 17-epimethandrostenolone is the primary marker used in anti-doping testing.